The Priority Review

Tag

CKD

1 story

  1. Clinical trials

    Bayer posts results of Phase 3 finerenone trial in CKD with type 1 diabetes

    The study, completed with 242 participants, compared finerenone plus standard of care to placebo in people with chronic kidney disease and type 1 diabetes. Results were first posted on ClinicalTrials.gov on October 27, 2026.